Article Text

PDF

BAS/BSCR YIA abstract
YIA2 11β-HSD1 deficiency attenuates atherosclerosis in ApoE−/− mice: role of both glucocorticoid and non-glucocorticoid (oxysterol) factors
  1. T Mitic,
  2. P W F Hadoke,
  3. S Chuaiphichai,
  4. T Y Man,
  5. E Miller,
  6. R Andrew,
  7. B R Walker,
  8. K E Chapman,
  9. J R Seckl
  1. Endocrinology Unit, Centre for Cardiovascular Sciences, The Queen's Medical Research Institute, University of Edinburgh, Scotland, UK

Abstract

11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) regenerates active glucocorticoids, amplifying intracellular actions.1 11β-HSD1 deficiency or inhibition improves metabolic syndrome and attenuates atherosclerosis in vulnerable rodent strains and is a target for drug development.2–4 However, 11β-HSD1 also catalyses conversion of 7-ketocholesterol,5 which accumulates in fatty tissues,6 to potentially more atherogenic 7β-hydroxycholesterol. Whether atheroprotection with 11β-HSD1 deficiency is dependent on glucocorticoid or oxysterol effects is unknown. Male atherosclerosis-prone ApoE−/− and ApoE−/−.11β-HSD1−/− double knockout (DKO) mice underwent adrenalectomy or sham surgery (n=8/group), then received a high (0.2%) cholesterol Western diet for 12 weeks. The aorta and branches were perfusion-fixed. Lesion volume and extracellular lipids were determined by 3D optical projection tomography. Data are mean±SE of the means. Adrenalectomy had no effect on body/organ weights in either genotype. Removal of endogenous glucocorticoids by adrenalectomy in ApoE−/− mice did not reduce lesion volume (232±24 vs 235±34 μm3 sham control). DKO mice had reduced lesion volumes (139±17 μm3) compared with ApoE−/−(p<0.05). Adrenalectomy reversed this effect (263±52 μm3).

Adrenalectomised DKO mice had increased extracellular lipids (73.6±2.6 μm3) within the lesion compared with either ApoE−/− adrenalectomised (37.4±5.2 μm3), ApoE−/− sham (42.9±5.5 μm3) or DKO sham (44.2±12 μm3) group. Thus circulating glucocorticoids are necessary for 11β-HSD1 deficiency to attenuate atherosclerosis. However, 11β-HSD1 deficiency increases the lipid content of plaques in the absence of glucocorticoids, perhaps owing to accumulation of 7-ketocholesterol? Consequently, both reactions of 11β-HSD1 may be involved in the effects of the enzyme on atherogenesis.

    Statistics from Altmetric.com

      Request permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.